TRC150094

DRUG2 trials

Sponsors

Torrent Pharmaceuticals Limited

Conditions

DiabetesDyslipidemiasHypertensionMetabolic Cardiovascular Syndrome

Phase 1

Hyperinsulinemic Euglycemic Clamp Protocol

CompletedNCT01408667

Torrent Pharmaceuticals LimitedMetabolic Cardiovascular Syndrome

Start: 2011-11-30Updated: 2012-07-10

Phase 3

Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension

Torrent Pharmaceuticals LimitedDiabetes, Dyslipidemias, Hypertension

Start: 2018-03-12End: 2022-08-31Target: 1250Updated: 2020-07-17

Related Papers

Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical Trial

Frontiers in Pharmacology2021-09-176 citations

The Effect of a Diiodothyronine Mimetic on Insulin Sensitivity in Male Cardiometabolic Patients: A Double-Blind Randomized Controlled Trial

PLoS ONE2014-02-2133 citations